Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix.
West
C M
CM
Paterson Institute for Cancer Research, Manchester, U.K.
Davidson
S E
SE
Hunter
R D
RD
D002470:Cell Survival / Q000528:radiation effects*; D005260:Female; D006801:Humans; D011379:Prognosis; D014407:Tumor Cells, Cultured / Q000528:radiation effects*; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000532:radiotherapy